CD131, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD131, Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD131, Human |
| Clone | REA249 |
| Host Species | Recombinant Human |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | allophycocyanin (APC) conjugate |
| Size | 30 tests in 300 µL |
| Concentration | 1:11 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD131 Antibody, anti-human, APC, REAfinity™. Clone REA249 recognizes the human CD131 antigen, a type I transmembrane glycoprotein also known as IL-3R common subunit β or GM-CSF/IL-3/IL-5 receptor common β chain. CD131 forms heterodimers with the α subunit of the receptor complexes for human granulocyte-macrophage colony stimulating factor (GM-CSFR), interleukin 3 (IL-3R), and interleukin 5 (IL-5R). These cytokine receptors are expressed by several different cell types like neutrophils, eosinophils, monocytes, endothelial cells, fibroblasts, and hematopoietic progenitor cells. | Additional information: Clone REA249 displays negligible binding to Fc receptors. |
| Immunogen | n/a |
| Other Names | CSF2RB, CDw131, IL3RB, IL5RB, SMDP5 |
| Gene, Accession # | Gene ID: 1439 |
| Catalog # | 130-104-035 |
| Price | $142 |
| Order / More Info | CD131, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Rossjohn, J. et al. (2000) Structure of the activation domain of the GM-CSF/IL-3/IL-5 receptor common beta-chain bound to an antagonist. Blood 95 (8): 2491-2498. | Hansen, G. et al. (2008) The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 134 (3): 496-507. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies